ExodusPoint Capital Management’s Madrigal Pharmaceuticals MDGL Stock Holding History

ExodusPoint Capital Management’s Portfolio MDGL Stock Details MDGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.92M	Buy	+5,570	New	+$2.66M	0.02%	629
2025 Q3	–	Sell	-2,878	Closed	-$871K	–	1830
2025 Q2	$871K	Buy	+2,878	New	+$857K	0.01%	1000
2024 Q4	–	Sell	-2,645	Closed	-$561K	–	1830
2024 Q3	$561K	Buy	+2,645	New	+$677K	﹤0.01%	1151
2023 Q4	–	Sell	-8,162	Closed	-$1.19M	–	1819
2023 Q3	$1.19M	Buy	+8,162	New	+$1.54M	0.01%	902
2023 Q2	–	Sell	-1,060	Closed	-$257K	–	2095
2023 Q1	$257K	Buy	+1,060	New	+$289K	﹤0.01%	1510
2022 Q4	–	Sell	-9,177	Closed	-$596K	–	1926
2022 Q3	$596K	Buy	9,177 +5,388	+142%	+$374K	0.01%	1302
2022 Q2	$271K	Buy	+3,789	New	+$279K	﹤0.01%	1568
2020 Q4	–	Sell	-2,089	Closed	-$248K	–	2208
2020 Q3	$248K	Buy	+2,089	New	+$227K	﹤0.01%	1375

Other funds holding MDGL

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ExodusPoint Capital Management's MDGL Position: Q1 2026 in Review

ExodusPoint Capital Management opened a new position in Madrigal Pharmaceuticals (MDGL) in Q1 2026: 5,570 shares worth $2.92M. The stake represents 0.02% of the portfolio and ranks #629 among its holdings. This is a return to the name: ExodusPoint Capital Management previously reported a position in MDGL as recently as Q2 2025.

ExodusPoint Capital Management first reported a position in MDGL in Q3 2020 and has held it in 8 quarters since. 378 funds tracked by Wall St. Rank hold MDGL as of Q1 2026.

ExodusPoint Capital Management held 5,570 shares of Madrigal Pharmaceuticals worth $2.92M as of Q1 2026.
Madrigal Pharmaceuticals was a new ExodusPoint Capital Management position in Q1 2026.
Madrigal Pharmaceuticals made up 0.02% of ExodusPoint Capital Management's portfolio in Q1 2026, its #629 holding.
ExodusPoint Capital Management first reported a position in Madrigal Pharmaceuticals in Q3 2020 and has held it in 8 quarters since.
378 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q1 2026.

Based on ExodusPoint Capital Management's 13F filing for Q1 2026, filed 14 May 2026.